Glass Wealth Management’s Pfizer PFE Stock Holding History

Glass Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.74M	Sell	96,210 -3,956	-4%	-$105K	0.87%	33
2026 Q2	$2.41M	Buy	100,166 +7,850	+9%	+$205K	0.81%	34
2026 Q1	$2.59M	Buy	92,316 +2,835	+3%	+$75.5K	1%	31
2025 Q4	$2.23M	Buy	89,481 +989	+1%	+$24.9K	0.91%	34
2025 Q3	$2.25M	Buy	88,492 +3,145	+4%	+$77.6K	1.01%	32
2025 Q2	$2.07M	Sell	85,347 -1,919	-2%	-$44.8K	1.1%	33
2025 Q1	$2.21M	Sell	87,266 -17,129	-16%	-$448K	1.33%	27
2024 Q4	$2.77M	Buy	104,395 +709	+0.7%	+$19.2K	1.51%	23
2024 Q3	$3M	Buy	103,686 +3,116	+3%	+$90.9K	1.66%	21
2024 Q2	$2.81M	Buy	100,570 +1,474	+1%	+$40.6K	1.65%	26
2024 Q1	$2.75M	Buy	+99,096	New	+$2.75M	1.68%	25

Other funds holding PFE

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Glass Wealth Management's PFE Position: Q3 2026 in Review

Glass Wealth Management reduced its Pfizer (PFE) stake by 3.9% in Q3 2026, selling an estimated $105K and leaving 96,210 shares worth $2.74M. The position accounts for 0.87% of the portfolio, ranked #33.

Glass Wealth Management first reported a position in PFE in Q1 2024 and has held it in 11 quarters since. The position peaked at $3M in Q3 2024. 2,002 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

Glass Wealth Management held 96,210 shares of Pfizer worth $2.74M as of Q3 2026.
Glass Wealth Management sold 3,956 Pfizer shares in Q3 2026, an estimated $105K.
Pfizer made up 0.87% of Glass Wealth Management's portfolio in Q3 2026, its #33 holding.
Glass Wealth Management first reported a position in Pfizer in Q1 2024 and has held it in 11 quarters since.
Glass Wealth Management's Pfizer position peaked at $3M in Q3 2024.
2,002 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Glass Wealth Management's 13F filing for Q3 2026, filed 28 Oct 2026.